ACPA-mediated activation of platelets is potentially of relevance for the earliest phases of RA because, during vascular injury, a tripartite interaction between the damaged endothelium, platelets and neutrophils develops. The gene discussed is PRTN3; the disease is rheumatoid arthritis.